GSK US news http://www.us-gsk.com/html/media-news/ GlaxoSmithKline is a leading healthcare company that helps people to do more, feel better and live longer. This RSS feed contains press releases and investor news. GSK further extends its product portfolio in the Middle East and North Africa http://us.gsk.com/html/media-news/pressreleases/2009/2009_pressrelease_10069.htm GSK today announced that it has acquired the branded generics business of Bristol Myers Squibb (BMS) in Lebanon, Jordan, Syria, Libya and Yemen for a cash consideration of $23.2m (£14.2m). Thu, 2 Jul 2009 09:00:00 GMT http://us.gsk.com/html/media-news/pressreleases/2009/2009_pressrelease_10069.htm Regulatory update for REZONIC™ (casopitant mesylate) http://us.gsk.com/html/media-news/pressreleases/2009/2009_us_pressrelease_10042.htm GlaxoSmithKline confirmed today that it has received a complete response letterfrom the FDA related to the application for casopitant. Tue, 23 June 2009 16:15:00 GMT http://us.gsk.com/html/media-news/pressreleases/2009/2009_us_pressrelease_10042.htm FDA extends review of Arzerra™ (ofatumumab) http://us.gsk.com/html/media-news/pressreleases/2009/2009_pressrelease_10065.htm GlaxoSmithKline and Genmab A/S today announced that the United States Food and Drug Administration (FDA) informed the companies that the agency has extended the action date for the ofatumumab BLA application by three months. Tue, 16 June 2009 11:15:00 GMT http://us.gsk.com/html/media-news/pressreleases/2009/2009_pressrelease_10065.htm GSK announces a strategic alliance with Dr. Reddy’s to further accelerate sales growth in emerging markets http://us.gsk.com/html/media-news/pressreleases/2009/2009_pressrelease_10064.htm GlaxoSmithKline plc (GSK) today announced an agreement with Dr. Reddy’s Laboratories Ltd (Dr. Reddy’s) to develop and market selected products across an extensive number of emerging markets, excluding India. Mon, 15 June 2009 12:45:00 GMT http://us.gsk.com/html/media-news/pressreleases/2009/2009_pressrelease_10064.htm GlaxoSmithKline update: A (H1N1) influenza vaccine development http://us.gsk.com/html/media-news/pressreleases/2009/2009_pressrelease_10063.htm The World Health Organisation (WHO) has announced it has raised the current level of influenza pandemic alert from phase 5 to phase 6. Fri, 12 Jun 2009 10:30:00 GMT http://us.gsk.com/html/media-news/pressreleases/2009/2009_pressrelease_10063.htm GSK and Shenzhen Neptunus create new alliance to develop and manufacture influenza vaccines in China http://us.gsk.com/html/media-news/pressreleases/2009/2009_pressrelease_10061.htm GSK today announced it has entered into a definitive agreement to form a new Joint Venture with Shenzhen Neptunus focused on developing and manufacturing influenza vaccines for the Chinese market. Tue, 09 Jun 2009 07:00:00 GMT http://us.gsk.com/html/media-news/pressreleases/2009/2009_pressrelease_10061.htm Study shows GSK’s novel diabetes treatment Syncria® (albiglutide) improves glucose control and reduces weight http://us.gsk.com/html/media-news/pressreleases/2009/2009_pressrelease_10060.htm New Phase II data presented today at the American Diabetes Association 69th Scientific Sessions in New Orleans show that the investigational type 2 diabetes treatment Syncria® (albiglutide) significantly reduced blood glucose levels and provided weight loss across weekly, biweekly and monthly dosing. Sun, 07 Jun 2009 14:00:00 GMT http://us.gsk.com/html/media-news/pressreleases/2009/2009_pressrelease_10060.htm Large, long-term study shows Avandia has no increased overall cardiovascular risk compared to other commonly used diabetes medicines http://us.gsk.com/html/media-news/pressreleases/2009/2009_pressrelease_10059.htm RECORD trial also demonstrates durable blood sugar control over time with Avandia Fri, 05 Jun 2009 21:15:00 GMT http://us.gsk.com/html/media-news/pressreleases/2009/2009_pressrelease_10059.htm GSK donates $100,000 to support breast health outreach http://us.gsk.com/html/media-news/pressreleases/2009/2009_us_pressrelease_10040.htm Funds will support Breast Health Outreach and Counseling Program in Philadelphia Wed, 03 Jun 2009 23:00:00 GMT http://us.gsk.com/html/media-news/pressreleases/2009/2009_us_pressrelease_10040.htm